Acute Respiratory Distress Syndrome (ARDS) Market: Current Analysis and Forecast (2024-2032)

Report Description

Global Acute Respiratory Distress Syndrome (ARDS) Market Size & Forecast

The Global Acute Respiratory Distress Syndrome (ARDS) Market was valued at ~USD 900 million in 2023 and is expected to grow at a strong CAGR of around ~8% during the forecast period (2024-2032) owing to the increasing prevalence of respiratory diseases worldwide.

Global Acute Respiratory Distress Syndrome (ARDS) Market Analysis

The market size of Acute Respiratory Distress Syndrome (ARDS) across the globe is expanding because of several factors such as the growing geriatric population prone to ARDS and technological advancements in respiratory care which will drive the growth of the market. Also advances in medical research and technology have led to the development of treatment options, which are gaining regulatory approvals and entering the market.

In April 2022, the Food and Drug Administration (FDA) approved Direct Biologics to proceed with a Landmark Phase 3 clinical trial using its investigation EV Drug ExoFlow to treat Acute Respiratory Distress Syndrome (ARDS).

Global Acute Respiratory Distress Syndrome (ARDS) Market Trends

This section discusses the key market trends that are influencing the various segments of the Global Acute Respiratory Distress Syndrome (ARDS) Market, as identified by our team of research experts.

Hospital Segment Transforming Industry

The hospital segment drives the Acute Respiratory Distress Syndrome (ARDS) Market by serving as the primary setting for diagnosing, treating, and managing ARDS patients. Hospitals, particularly intensive care units (ICUs), require specialized equipment such as mechanical ventilators, ECMO machines, and advanced monitoring systems to provide critical respiratory support. The demand for these technologies is propelled by the increasing incidence of ARDS, often precipitated by conditions like pneumonia, sepsis, and COVID-19. Hospitals also drive market growth through their role in clinical research, testing new therapies and protocols aimed at improving ARDS outcomes. As pivotal hubs for acute care, hospitals play a crucial role in shaping the ARDS market landscape by driving innovation and ensuring access to lifesaving treatments for critically ill patients.

Asia-Pacific is Expected to Grow at a fastest CAGR During Forecast Period

The Asia-Pacific Acute Respiratory Distress Syndrome (ARDS) Market is characterized by increasing prevalence of ARDS due to factors like rising geriatric population, higher incidence of pneumonia and sepsis, and expanding healthcare infrastructure. The market sees growing adoption of advanced ventilation techniques and ECMO technologies, along with ongoing research and development efforts aimed at optimizing treatment outcomes. Government initiatives to improve critical care capabilities, coupled with collaborations between healthcare providers and technology firms, are driving market growth. Challenges include variability in healthcare access across different regions and the need for cost-effective solutions tailored to diverse economic conditions within the Asia-Pacific region.

Global Acute Respiratory Distress Syndrome (ARDS) Industry Overview

The Global Acute Respiratory Distress Syndrome (ARDS) Market is competitive, with several global and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new type launches, geographical expansions, and mergers and acquisitions. Some of the major players operating in the market are Fisher & Paykel Healthcare Limited; Biomark Pharma; Athersys, Inc.; Healios Ltd; Direct Biologics LLC; Biohaven, Ltd.; Arch Biopartners; Staidson Biopharma Inc.; MediciNova, Inc; Edesa Biotech, Inc.

Global Acute Respiratory Distress Syndrome (ARDS) Market Report Coverage

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
• The report presents a quick review of overall industry performance at one glance.
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, portfolios, expansion strategies, and recent developments.
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
• The study comprehensively covers the market across different segments.
• Deep dive regional level analysis of the industry.

Customization Options:

The Global Acute Respiratory Distress Syndrome (ARDS) Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to contact us to get a report that completely suits your requirements.

Frequently Asked Questions (FAQ)

You can also purchase parts of this report. Do you want to check out a section wise
price list?

Get in touch with team

Research Methodology

Research Methodology for the Global Acute Respiratory Distress Syndrome (ARDS) Market Analysis (2024-2032)

Analyzing the historical market, estimating the current market, and forecasting the future market of the Global Acute Respiratory Distress Syndrome (ARDS) Market were the three major steps undertaken to create and analyze the adoption of global acute respiratory distress syndrome (ARDS) in major regions. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global acute respiratory distress syndrome (ARDS) market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

A detailed secondary study was conducted to obtain the historical market size of the Global Acute Respiratory Distress Syndrome (ARDS) Market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the Global Acute Respiratory Distress Syndrome (ARDS) Market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as treatment, end-user, and regions. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the global acute respiratory distress syndrome (ARDS) market. Further, we conducted factor analysis using dependent and independent variables such as treatment and end-user, and regions of the global acute respiratory distress syndrome (ARDS) market. A thorough analysis was conducted of demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and type launches in the global acute respiratory distress syndrome (ARDS) market sector across the globe.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global acute respiratory distress syndrome (ARDS) market, and market shares of the segments. All the required percentage shares split and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to several factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2032 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

• The industry’s market size, in terms of revenue (USD) and the adoption rate of the Global Acute Respiratory Distress Syndrome (ARDS) market across the major markets domestically
• All percentage shares, splits, and breakdowns of market segments and sub-segments
• Key players in the Global Acute Respiratory Distress Syndrome (ARDS) market in terms of types offered. Also, the growth strategies adopted by these players to compete in the fast-growing market

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Market Engineering

The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the Global Acute Respiratory Distress Syndrome (ARDS) Market. Data was split into several segments and sub-segments after studying various parameters and trends in the treatment and end-user, and regions in the Global Acute Respiratory Distress Syndrome (ARDS) Market.

The main objective of the Global Acute Respiratory Distress Syndrome (ARDS) Market Study

The current & future market trends of the Global Acute Respiratory Distress Syndrome (ARDS) Market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the market’s overall attractiveness at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:

• Analyze the current and forecast market size of the Global Acute Respiratory Distress Syndrome (ARDS) Market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments.
• Segments in the study include areas of the treatment, end-user, and regions.
• Define and analyze the regulatory framework for the industry.
• Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry.
• Analyze the current and forecast market size of the Global Acute Respiratory Distress Syndrome (ARDS) Market for the major regions.
• Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World
• Company profiles of the Global Acute Respiratory Distress Syndrome (ARDS) Market and the growth strategies the players adopt to sustain in the fast-growing market.
• Deep dive regional level analysis of the industry

You can also purchase parts of this report. Do you want to check out a section wise
price list?

Get in touch with team